Center for Molecular Medicine Cologne

Honors and Awards 2020

November 2020

Dr. Philipp Schommers

Assistant physician at the Clinic I for Internal Medicine (Director: Prof. Dr. Michael Hallek), has been awarded the Wolfgang Stille Science Prize 2020 by the Paul Ehrlich Society for Chemotherapy (PEG). He receives the prize for his research on new antibody therapies against HIV infections.  The described work was performed by Dr. Schommers in the Laboratory for Experimental Immunology under the direction of Prof. Dr. Florian Klein.

This highest award of the PEG reminds of the infectiologist and former chairman of the PEG, Prof. Dr. Wolfgang Stille (1935-2004). Every two years it honors outstanding clinical-experimental research in the fields of infectiology and medical microbiology.

Prof. Dr. Claus Cursiefen

Director of the Department of Ophthalmology at University Hospital Cologne - was elected by the Deutsche Ophthalmologische Gesellschaft (DOG) as their Secretary General of the Society at its 118th Annual Meeting in Berlin - initially for four years. As Secretary General, Prof. Dr. Cursiefen has the task of ensuring the continuity of the DOG's work on fundamental issues. The DOG is the expert representation of scientific ophthalmology and with over 7,750 members the oldest ophthalmological society in the world.

Prof. Dr. Claus Cursiefen is Co-Prinicipal Investigator of the CMMC-Project:
A 09 - Role and therapeutic potential of autophagy-related mechanisms in UV-induced blinding ocular stem cell disorders (Pterygium)


Prof. Dr. Roman-Ulrich Müller

Clinic II of Internal Medicine was awarded the Carl Ludwig Prize of the German Society of Nephrology (DGfN) for outstanding scientific work in the field of kidney and hypertension. The prize honors his work in translational nephrological research. His group uses various model organisms in combination with state-of-the-art methods of RNA biology to better understand kidney diseases.

Prof. Dr. Roman-Ulrich Müller is Principal Investigator of the CMMC-Project:
assoc. RG 13 - Hypoxia-signaling at the crossroads of cellular stress resistance and tumorigenesis

Oktober 2020

Prof. Dr. Dr. Heidenreich

Director of the Clinic and Polyclinic of Urology and Uro-Oncology University Hospital, has been awarded the Wil de Jongh Medal by the German Federal Association for Prostate Cancer Self-help (BPS) e.V. for his above-average commitment, his strong patient orientation and his support of self-help. The metabolism researcher receives the renowned science award for his outstanding research to identify pathological processes in the development of insulin resistance in obesity and diabetes mellitus. According to the Federal Association, his commitment is characterized by extraordinary dedication. With this award, the BPS honors high scientific competence, above-average commitment and, in particular, the pronounced patient-orientation of a clinically active or practicing physician.

Prof. Dr. Dr. Heidenreich is Co-Principal Investigator of the CMMC-Project:

assoc. RG 15 - Exploiting tumor heterogeneity and tumor microenvironment interactions in Testicular Germ Cell Tumors (TGCT) impacting metastasis and therapy response

September 2020

Prof. Dr. Jens C Brüning

Director at the Max Planck Institute for Metabolism Research and Center for Endocrinology, Diabetology and Prev. Medicine, University Hospital Cologne - has been honoured with the 2020 EASD-Novo Nordisk Foundation Diabetes Prize for Excellence for his scientific contributions to the understanding of the interactions between peripheral organs and the brain, which have come to the fore in recent years in the struggle to understand the escalating epidemics of type 2 diabetes and obesity.

Prof. Dr. Jens C Brüning is Principal Investigator of the CMMC-Project:
C 05 - Role of prepronociceptin (PNOC)-expressing neurons in the development of obesity

Dr. Xialoei Ding

Clinic and Polyclinic of Dermatology and Venerology, has been awarded the ROSA Research Prize 2020. The prize honors research that is leading the way in the pathogenesis, prevention or therapy of pathologically dry skin. The scientific assistant of the Clinic for Dermatology and Venerology and the Medical Faculty works in the team of the research laboratory on regeneration and inflammation of the skin under the direction of Univ.-Prof. Dr. Sabine Eming.

Prof. Dr. Sabine Eming is Principal Investigator of the CMMC-Project:
C 06 - Metabolic regulation of myeloid cells in tissue repair and regeneration

July 2020

Prof. Dr. Rita Schmutzler

head of the Center for Familial Breast- and Ovarian Cancer, University Hospital of Cologne, has been appointed to the board of the Technologie- und Methodenplattform für die vernetzte medizinische Forschung e. V. (TMF)(Technology and Methods Platform for Networked Medical Research). Germany's medical network researchers have joined forces through this platform. As a board member Prof. Schmutzler intends to focus especially in the further development of clinical registries for health care research. Special attention will also be paid to the requirements for data protection and for the network of clinical and genetic data to help generate new knowledge through "big data" analyses.

Prof. Dr. Rita Schmutzler is Principal Investigator of the CMMC project:
Rita Schmutzler - assoc. RG 20

May 2020

Prof. Dr. Sandra Iden

current CECAD Research Group Leader, recently accepted a tenured professorship for cell and developmental biology at Saarland University, Faculty of Medicine, Campus Homburg, commencing January 2020. At Saarland University, the Iden lab will expand its ongoing efforts to dissect both intrinsic and non-autonomous mechanisms that safeguard mammalian tissue integrity in development, homeostasis and disease.

Prof. Dr. Sandra Iden is Principal Investigator of the CMMC-Project:
B 03 - Tissue-scale control of epidermal immunity by polarity networks in homeostasis and disease

Prof. Dr. Thomas Benzing

Clinic II of Internal Medicine and Chair of the Center for Molecular Medicine Cologne has been awarded the membership in the North Rhine-Westphalian Academy of Sciences and Arts. He is considered a pioneer in the field of molecular causes of kidney disease and has contributed to the development of innovative therapies for this illness with his research.

Prof. Dr. Thomas Benzing is Principal Investigator of the CMMC project:
C 02 - Cellular crosstalk of endothelial cells and podocytes in glomerular injury and repair

Dr. Ron Jachimowicz

Clinic I of Internal Medicine, University Hospital of Cologne was honoured with the Theodor-Frerichs-Prize, the highest award given by the Deutsche Gesellschaft für Innere Medizin e.V. (DGIM - German Society for Internal Medicine), for his recent discovery that the protein UBQLN4 plays a major role in the cells' decision how to repair serious damage to DNA, choosing between an error-prone and an error-free repair route.

Dr. Ron Jachimowicz is Co-Principal Investigator of the CMMC project:
A 10 - Exploring the efficacy of PARP1 inhibition and anti-PD1 treatment for UBQLN4-overexpressing KRAS-driven lung adenocarcinoma

Prof. Dr. Mats Paulsson

Institute for Biochemistry II, University Hospital of Cologne was awarded an honorary doctorate by the Faculty of Biochemistry and Molecular Medicine of the Universität of Oulu, Finnland, for his many years of commitment and pioneering research in the field of matrix biology.

February 2020

Prof. Dr. Rita Schmutzler

Center for Familial Breast- and Ovarian Cancer, University Hospital of Cologne has been awarded with the Deutsche Krebpreis (German Cancer Award) which is sponsored by the Deutschen Krebsgesellschaft (German Cancer Society) and the Deutschen Krebsstiftung (German Cancer Foundation), is one of the highest awards in German cancer medicine.

Prof. Dr. Rita Schmutzler is Principal Investigator of the CMMC project:
Rita Schmutzler - assoc. RG 20